Van der HeideAJacobsJWGBijlsmaJWJ. The effectiveness of early treatment with ‘second line’ antirheumatic drugs. A randomized, controlled trial. Ann Intern Med1996; 124:699707.
2.
TugwellPPincusTYocumD. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med1995; 333:137–41.
3.
FelsonDTAndersonJJMeenanRF. The efficacy and toxicity of combination therapy in rheumatoid arthritis: A meta-analysis. Arthritis Rheum1994; 37:1487–91.
4.
MainiRNElliottMJBrennanFMFeldmannM. Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis. Clin Exp Immun1995; 101:207–12.
5.
IsaacsJDWattsRAHazlemanBLHaleGKeoganMTCobboldSPWaldmannH. Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet1992; 340:7482.
6.
JennetteJCFalkRJAndrassyK. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. [Review]. Arthritis Rheum1994; 37:187–92.
7.
ScottDGIWattsRA. Classification and epidemiology of systemic vasculitis. Br J Rheumatol1994; 33:897–900.
8.
AduDPallALuqmaniRA. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Q J Med1997; 90:401–9.
9.
GordonMLuqmaniRAAduD. Relapses in patients with a systemic vasculitis. Q J Med1993; 86:77990.
10.
HoffmanGSKerrGSLeavittRY. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med1992; 116:488–98.
11.
WallaceCALevinsonJE. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum Dis Clin North Am1991; 17:891–905.
12.
Andersson GareBFasthA. The natural history of juvenile chronic arthritis: a population based cohort study II. Outcome. J Rheumatol1995; 22:308–19.
13.
RupertoNLevinsonJERavelliA. Long term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis I. Outcome status. J Rheumatol1997; 24:945–51.
14.
ShaikovAVMaximovAASperanskyAILovellDJGianniniEHSolovyevSK. Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis - preliminary results of a long term study. J Rheumatol1992; 19:612–16.
15.
HochbergMCAltmanRDBrandtKDClarkBMDieppePAGriffinMRMoskowitzRWSchnitzerTJ. Guidelines for the medical management of osteoarthritis Part II. Osteoarthritis of the knee. Arthritis Rheum1995; 38:1541–6.
16.
HochbergMCAltmanRDBrandtKD. Guidelines for the medical management of osteoarthritis: Part I. Osteoarthritis of the hip. Arthritis Rheum1995; 38:1535–40.
17.
CushnaghanJMcCarthyCDieppeP. Taping the patella medially: A new treatment for osteoarthritis of the knee joint?BMJ1994; 308:753–5.
18.
DougadosMDevogelaerJPAnnefeldtM. Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis1996; 55:552–7.
19.
CaldwellJR. Intra-articular corticosteroids. Guide to selection and indications for use. Drugs1996; 52:507–14.
20.
JonesAReganMLedinghamJPattrickMManhireADohertyM. Importance of placement of intra-articular steroid injections. BMJ1993; 307:1329–30.
21.
MathewsJAMillsSBJenkinsVM. Back pain and sciatica: controlled trials of manipulation, traction, sclerosant and epidural injections. Br J Rheumatol1987; 26:416–23.
22.
FitzpatrickRNewmanSLambRShipleyM. A comparison of measures of health status in rheumatoid arthritis. Br J Rheumatol1989; 28:201–6.
23.
NewmanS. Coping with rheumatoid arthritis. Ann Rheum Dis1993; 52:553–4
24.
WolfeF. The natural history of rheumatoid arthritis. J Rheumatol1996; Vol 23(Suppl 44): 13–22.
25.
HawleyDJWolfeF. Are the results of controlled clinical trials and observational studies of second line therapy in rheumatoid arthritis valid and generalizable as measures of rheumatoid arthritis outcome: analysis of 122 studies. J Rheumatol1991; 18:100814.
26.
FriesJFWilliamsCAMorfeldDSinghGSibleyJ. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum1996; 39:616–22.
27.
SharpJTWolfeFMitchellDMBlochDA. The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum1991; 34: 660–8.
28.
WolfeFHawleyDJCatheyMA. Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis. J Rheumatol1991; 18:1290–7.
29.
WolfeF. A database for rheumatoid arthritis. Rheum Dis Clin North Am1995; 21:481–500.
30.
WolfeFMitchellDMSibleyJT. The mortality of rheumatoid arthritis. Arthritis Rheum1994; 37:481–94.